Pfizer released full tafamidis data demonstrating a 30% reduction (29.5% vs 42.9%) in the risk of all-cause mortality and a 32% reduction in CV-related hospitalizations. The market has ...

The Food and Drug Administration issued a final guidance on Monday for how and when existing clinical data should be used to support pediatric medical device indications and labeling. The guidance ...

Both epidemiology and laboratory data can contribute to estimates of risks to humans of exposure to low doses of carcinogens. The sum of all these contributions does not permit us to make these ...

Opinions expressed by Entrepreneur contributors are their own. AI use in business is growing at an exponential rate. Industries as varied as cybersecurity and retail are now leveraging its power to ...